‘Phase II Study with Immunotherapy with Dendritic Cells and Hiltonol in Patients with Advanced Solid Tumors: Evaluation of the Abscopal Effect’

Grants for research teams

Biomedicine

Oncology

2014

In an ongoing clinical trial we are evaluating administration of intratumoral Hiltonol (thus avoiding systemic toxicity) with vaccination with dendritic cells (DC) that present tumor antigens, as a treatment for solid tumors.